Abstract Background Despite evidence-based guidelines, aspirin prescribing for the secondary prevention of stroke is sub-optimal. Little is known about why general practitioners do not prescribe aspirin to indicated patients. We sought to identify and describe factors that lead general practitioners (GPs) not to prescribe aspirin to eligible stroke patients. This was the first stage of a study exploring the need for and means of improving levels of appropriate aspirin prescribing. Method Qualitative interviews with 15 GPs in the West Midlands. Results Initially, many GPs did not regard their prescribing as difficult or sub-optimal. However on reflection, they gave several reasons that lead to them not prescribing aspirin for eligible patien...
BackgroundBy screening and modifying risk factors, stroke incidence can be reduced. Clinical guideli...
Stroke is a leading cause of death and disability; worldwide it is estimated that 16.9 million peopl...
Aims: To assess the attitudes of Australian doctors towards the use of antithrombotic drug therapy f...
BACKGROUND: Despite evidence-based guidelines, aspirin prescribing for the secondary prevention of s...
Background: The National Institute for Health and Care Excellence (NICE) recommends aspirin for colo...
Background/Aims: The U.S. Preventive Services Task Force (USPSTF) currently recommends aspirin for p...
Background The National Institute for Health and Care Excellence (NG151) recommends considering dai...
Summary: A questionnaire was sent to all 155 consultant physicians and geriatricians in the Yorkshir...
A dose non-inferiority study comparing 100 mg, 300 mg and 600 mg of aspirin for cancer prevention am...
The aim of this study was to gain understanding into compliance behaviour with aspirin as prescribed...
Background: The U.S. Preventive Services Task Force (USPSTF) recommends aspirin for primary preventi...
A spirin for primary prevention of cardiovascular disease(CVD) remains a challenging issue for clini...
Background-—Aspirin use has been shown to be an effective tool in cardiovascular disease (CVD) preve...
Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are widely prescribed in primary care des...
Abstract Background There are now effective drugs to prevent cardiovascular disease and guidelines r...
BackgroundBy screening and modifying risk factors, stroke incidence can be reduced. Clinical guideli...
Stroke is a leading cause of death and disability; worldwide it is estimated that 16.9 million peopl...
Aims: To assess the attitudes of Australian doctors towards the use of antithrombotic drug therapy f...
BACKGROUND: Despite evidence-based guidelines, aspirin prescribing for the secondary prevention of s...
Background: The National Institute for Health and Care Excellence (NICE) recommends aspirin for colo...
Background/Aims: The U.S. Preventive Services Task Force (USPSTF) currently recommends aspirin for p...
Background The National Institute for Health and Care Excellence (NG151) recommends considering dai...
Summary: A questionnaire was sent to all 155 consultant physicians and geriatricians in the Yorkshir...
A dose non-inferiority study comparing 100 mg, 300 mg and 600 mg of aspirin for cancer prevention am...
The aim of this study was to gain understanding into compliance behaviour with aspirin as prescribed...
Background: The U.S. Preventive Services Task Force (USPSTF) recommends aspirin for primary preventi...
A spirin for primary prevention of cardiovascular disease(CVD) remains a challenging issue for clini...
Background-—Aspirin use has been shown to be an effective tool in cardiovascular disease (CVD) preve...
Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are widely prescribed in primary care des...
Abstract Background There are now effective drugs to prevent cardiovascular disease and guidelines r...
BackgroundBy screening and modifying risk factors, stroke incidence can be reduced. Clinical guideli...
Stroke is a leading cause of death and disability; worldwide it is estimated that 16.9 million peopl...
Aims: To assess the attitudes of Australian doctors towards the use of antithrombotic drug therapy f...